Importantly, we believe that the KDM6A-TLE1-HES1 regulatory axis we defined makes a valuable contribution to the understanding of epigenetic deregulation in bladder cancer with regard to the mutations observed in KDM6A. This evidence concerns the gene KDM6A and urinary bladder carcinoma.